Carregant...
Lipoic acid in secondary progressive MS: A randomized controlled pilot trial
OBJECTIVE: To determine whether lipoic acid (LA), an endogenously produced antioxidant, slowed the whole-brain atrophy rate and was safe in secondary progressive MS (SPMS). METHODS: Patients with SPMS aged 40–70 years enrolled in a single center, 2-year, double-blind, randomized trial of daily oral...
Guardat en:
| Publicat a: | Neurol Neuroimmunol Neuroinflamm |
|---|---|
| Autors principals: | , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Lippincott Williams & Wilkins
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5489387/ https://ncbi.nlm.nih.gov/pubmed/28680916 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000374 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|